Composition of active ingredient of traditional chinese medicine and use thereof
A technology of active ingredients and compositions, which is applied in the field of active ingredients and compositions of traditional Chinese medicine, and can solve problems such as lack of pharmaceutical preparations
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
preparation example Construction
[0035] (1) The preparation of ginsenoside monomer Rf1 is prepared with reference to the patented method (the medical use of ginsenoside F1, application number 200610008477.X);
[0036] (II) The preparation of ginsenoside monomer Re is carried out with reference to the patented method (new medical application and preparation method of ginsenoside Re, application number 2004110021133.6);
[0037] (III) The preparation of ginsenoside monomer Rg1 refers to the patented method for preparation (the use of ginsenoside Rg1, application number 200810227643.4);
[0038] (IV) The preparation of ginsenoside monomer Rb1 refers to the patented method (a preparation method of ginsenoside Rb1, application number 200710178212.9);
[0039] (V) The preparation of ginsenoside monomer Rh (Rh1 and Rh2) is prepared by referring to the patent method (ginsenoside Rh extract and preparation method, application number 200810043537.0);
[0040] (VI) The preparation of ginsenoside monomer Rd was prepared...
Embodiment 1
[0048] Example 1: The composition of the present invention has a protective effect on animals with acute focal cerebral ischemia.
[0049] Animal model establishment of acute focal cerebral ischemia (middle cerebral artery embolization (MCAO) operation)
[0050] Male SD rats with a body weight of 250-270g were used, referring to the rats established by Zea Longa et al. Methods of occlusion of the middle cerebral artery with thread embolization. 400 mg / kg of 10% chloral hydrate solution was injected intraperitoneally to anesthetize the animal. Rats were fixed in the supine position, the skin was incised in the middle of the neck, and all layers of tissue were bluntly separated to expose the right common carotid artery (CCA). After the bifurcation of the internal carotid artery (ICA) and external carotid artery (ECA), it was separated carefully to avoid damage to the vagus nerve and trachea, and the line was placed for use. The ipsilateral external carotid artery was separate...
Embodiment 2
[0077]Example 2 Research experiment on the protective effect of the composition of the present invention on the reperfusion after ischemia in animals with focal cerebral ischemia
[0078] Preparation of ischemia-reperfusion model after middle cerebral artery occlusion (MCAO)
[0079] Male SD rats with a body weight of 250-270g were used, referring to the rats established by Zea Longa et al. Appropriate improvements were made to the method of occlusion of the middle cerebral artery with thread embolization.
[0080] 400 mg / kg of 10% chloral hydrate solution was injected intraperitoneally to anesthetize the animal. Rats were fixed in the supine position, the skin was incised in the middle of the neck, and all layers of tissue were bluntly separated to expose the right common carotid artery (CCA). After the bifurcation of the internal carotid artery (ICA) and external carotid artery (ECA), it was separated carefully to avoid damage to the vagus nerve and trachea, and the line w...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com